- Home
- CMPR vs CRMD Comparison
CMPR vs CRMD Comparison
Compare CMPR & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPR
- CRMD
- Stock Information
- Founded
- CMPR 1994
- CRMD 2006
- Country
- CMPR Ireland
- CRMD United States
- Employees
- CMPR N/A
- CRMD N/A
- Industry
- CMPR Publishing
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- CMPR Consumer Discretionary
- CRMD Health Care
- Exchange
- CMPR Nasdaq
- CRMD Nasdaq
- Market Cap
- CMPR 1.1B
- CRMD 973.3M
- IPO Year
- CMPR N/A
- CRMD 2010
- Fundamental
- Price
- CMPR $49.68
- CRMD $11.62
- Analyst Decision
- CMPR Strong Buy
- CRMD Strong Buy
- Analyst Count
- CMPR 2
- CRMD 7
- Target Price
- CMPR $62.50
- CRMD $17.33
- AVG Volume (30 Days)
- CMPR 321.9K
- CRMD 2.5M
- Earning Date
- CMPR 07-30-2025
- CRMD 08-13-2025
- Dividend Yield
- CMPR N/A
- CRMD N/A
- EPS Growth
- CMPR 83.61
- CRMD N/A
- EPS
- CMPR 5.97
- CRMD 0.28
- Revenue
- CMPR $3,366,207,000.00
- CRMD $82,553,827.00
- Revenue This Year
- CMPR $4.65
- CRMD $238.38
- Revenue Next Year
- CMPR $3.16
- CRMD $53.52
- P/E Ratio
- CMPR $8.34
- CRMD $41.86
- Revenue Growth
- CMPR 3.64
- CRMD N/A
- 52 Week Low
- CMPR $35.21
- CRMD $3.61
- 52 Week High
- CMPR $104.92
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- CMPR 66.92
- CRMD 39.52
- Support Level
- CMPR $45.78
- CRMD $12.14
- Resistance Level
- CMPR $50.82
- CRMD $17.43
- Average True Range (ATR)
- CMPR 1.96
- CRMD 0.69
- MACD
- CMPR 0.52
- CRMD -0.51
- Stochastic Oscillator
- CMPR 87.00
- CRMD 4.60
About CMPR Cimpress plc (Ireland)
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.